title: [Early diabetic nephropathy and cardiovascular disease in a Mediterranean population: risk factors and treatment intensity].
abstract: The objective of this cross-sectional study was to evaluate the impact of early diabetic nephropathy on the presence of cardiovascular disease (CVD) in a Mediterranean population, as well as the prevalence in these patients of traditional cardiovascular risk factors and its treatment intensity in accordance with international recommendations. In 123 patients with type 2 diabetes and incipient nephropathy the presence of CVD, smoking, hypertension, dyslipemia, and their treatment was recorded. CVD prevalence was 34%. Age, nephropathy stage (micro/macroalbuminuria), and smoking were associated with the presence of CVD. Hypertension, dyslipemia, and smoking were present in 83%, 81%, and 59%, respectively. Coexistence of several risk factors was frequent and was associated with a higher incidence of CVD. 79% hypertensive patients and 43% dyslipemic patients received pharmacological treatment but only 17% and 9%, respectively, reached a good control of their disease. Patients with known CVD showed also a deficient control. Accordingly, early diabetic nephropathy induces a multiplier effect on the cardiovascular risk of a Mediterranean population. Higher prevalence and association with cardiovascular risk factors, with smoking in a predominant role, are associated with this higher risk. Despite this, the intensity of treatment and control of these risk factors is deficient, which means that a better and more intensive treatment should reduce the morbidity and mortality in these patients.
authors.affiliation: Servicio de Endocrinología, Hospital Universitario de Bellvitge, Barcelona, Spain. mmperez@csub.scs.es
authors.forename: M
authors.initials: M
authors.lastname: Pérez-Maraver
authors.forename: M J
authors.initials: MJ
authors.lastname: Carrera Santaliestra
authors.forename: G
authors.initials: G
authors.lastname: Vinzia Uriach
authors.forename: T
authors.initials: T
authors.lastname: Micaló Durán
authors.forename: N
authors.initials: N
authors.lastname: Gómez Arnaiz
authors.forename: M
authors.initials: M
authors.lastname: Sahún de la Vega
authors.forename: J
authors.initials: J
authors.lastname: Soler Ramón
authors.forename: E
authors.initials: E
authors.lastname: Montanya Mías
mesh_terms: D000368:Aged; D000419:Albuminuria / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000453:epidemiology* / Q000209:etiology; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000453:epidemiology* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D019083:Mediterranean Region / Q000453:epidemiology; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors